Home › Funds › Covalent Partners LLC › BLCO
Covalent Partners LLC position in BLCO
BAUSCH PLUS LOMB CORP · Health Care
Covalent Partners LLC reported holding 65,000 shares of BLCO (BAUSCH PLUS LOMB CORP) in its Q1 2026 13F filing — a position valued at US$1.0M, representing 5.89% of its reported portfolio and ranking #7 among its reported holdings. Covalent Partners LLC has disclosed BLCO holdings in 3 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Covalent Partners LLC's BLCO position evolved
Covalent Partners LLC first disclosed a stake in BLCO in Q3 2023 at 12,200 shares (US$207K). The position peaked in Q1 2026 at 65,000 shares, worth US$1.0M. Across 3 filings, Covalent Partners LLC held the position steady without any share-count change. The most recent filing (Q1 2026) shows 65,000 shares valued at US$1.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.20K | $206.79K | New |
| Q4 2023 | 12.20K | $208.13K | Hold |
| Q1 2026 | 65.00K | $1.03M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BLCO and 13F data
BLCO (BAUSCH PLUS LOMB CORP) is a Health Care company. 25 other funds we track also report a position in BLCO — the largest reported positions include ICAHN CARL C (US$58.0M), OAKTREE CAPITAL MANAGEMENT LP (US$57.0M), Davidson Kempner Capital Management (US$52.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BLCO
- ICAHN CARL C 3.50M sh · $57.96M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 3.44M sh · $56.98M · Q2 2026
- Davidson Kempner Capital Management 3.16M sh · $52.31M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 2.66M sh · $43.96M · Q2 2026
- CASPIAN CAPITAL LP 2.00M sh · $33.10M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 1.92M sh · $31.76M · Q2 2026
- CLARK ESTATES INC/NY 881.00K sh · $14.59M · Q2 2026
- Clearline Capital LP 701.97K sh · $11.62M · Q2 2026
- GordonMD Global Investments LP 573.47K sh · $9.50M · Q2 2026
- Ratan Capital Management LP 383.71K sh · $6.35M · Q2 2026
More on Covalent Partners LLC
FAQ
How long has Covalent Partners LLC held BLCO?
Covalent Partners LLC has disclosed BLCO holdings in 3 of the last 11 reported quarters, going back to Q3 2023.
What is Covalent Partners LLC's current position in BLCO?
As of Q1 2026, Covalent Partners LLC holds 65.00K shares of BLCO (BAUSCH PLUS LOMB CORP), valued at $1.03M, representing 5.89% of its reported portfolio and ranking #7.
Has Covalent Partners LLC been buying or selling BLCO?
In the latest 13F filing (Q1 2026), Covalent Partners LLC newly opened its position in BLCO. The position peaked in Q1 2026 at 65.00K shares.
Which other funds hold BLCO?
Other major institutional holders of BLCO include ICAHN CARL C, OAKTREE CAPITAL MANAGEMENT LP, Davidson Kempner Capital Management, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.